oritavancin structure
|
Common Name | oritavancin | ||
|---|---|---|---|---|
| CAS Number | 171099-57-3 | Molecular Weight | 1793.10000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C86H97Cl3N10O26 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of oritavancinOritavancin (LY 333328) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin shows antibacterial effect against multidrug-resistant S. pneumoniae. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential[1][2]. |
| Name | oritavancin |
|---|---|
| Synonym | More Synonyms |
| Description | Oritavancin (LY 333328) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin shows antibacterial effect against multidrug-resistant S. pneumoniae. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C86H97Cl3N10O26 |
|---|---|
| Molecular Weight | 1793.10000 |
| Exact Mass | 1790.56000 |
| PSA | 560.98000 |
| LogP | 8.57000 |
| InChIKey | VHFGEBVPHAGQPI-LXKZPTCJSA-N |
| SMILES | CNC(CC(C)C)C(=O)NC1C(=O)NC(CC(N)=O)C(=O)NC2C(=O)NC3C(=O)NC(C(=O)NC(C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)C(OC3CC(C)(N)C(O)C(C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3OC2OC(CO)C(O)C(O)C2OC2CC(C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)C(O)C(C)O2)Oc2ccc(cc2Cl)C1O |
| Hazard Codes | Xn |
|---|
| LY333328 |
| Orbactiv |